Zhang, Chao http://orcid.org/0009-0009-0451-3077
Rehman, Michael
Tian, Xin
Pei, Steven Lim Cho http://orcid.org/0000-0003-1335-5380
Gu, Jianlei
Bell, Thomas A. 3rd
Dong, Ke http://orcid.org/0000-0002-1943-017X
Tham, Ming Shen http://orcid.org/0000-0003-1726-0899
Cai, Yiqiang http://orcid.org/0000-0001-9632-7275
Wei, Zemeng http://orcid.org/0000-0002-4865-3866
Behrens, Felix http://orcid.org/0000-0002-6841-4192
Jetten, Anton M.
Zhao, Hongyu http://orcid.org/0000-0003-1195-9607
Lek, Monkol http://orcid.org/0000-0003-1227-6293
Somlo, Stefan http://orcid.org/0000-0001-5062-4629
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK120911, DK120534, DK100592)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Amy P. Goldman Foundation Mr. and Mrs. Robert Roth
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (Z01-ES-100485)
Article History
Received: 2 June 2023
Accepted: 15 April 2024
First Online: 1 May 2024
Competing interests
: S.S. is a consultant for, and a scientific co-founder with equity interest in Sen Therapeutics. T.A.B.3rd was an employee of Ionis Pharmaceuticals at the time of this study. There are no more competing interests.